Generics
Azurity Pharmaceuticals completes Slayback Pharma acquisition
28 September 2023 - Azurity Pharmaceuticals, Inc., a US-based privately-held pharmaceutical company, announced on Wednesday that it has completed the acquisition of Slayback Pharma LLC, a New Jersey-b...
Sandoz secures European approval for Tyruko biosimilar in MS treatment
26 September 2023 - Generic and biosimilar medicines provider Sandoz, part of Swiss pharmaceutical company Novartis Pharma AG (SIX:NOVN) (NYSE:NVS), announced on Tuesday that the European Commission h...
Senores Pharmaceuticals introduces Nicardipine Hydrochloride Capsules USP, 20mg and 30mg in US
26 September 2023 - United States-based Senores Pharmaceuticals, Inc announced on Monday that it has launched its Nicardipine Hydrochloride Capsules USP, 20mg and 30mg, a bioequivalent and therapeutic...
Lupin collaborates with Mark Cuban Cost Plus Drug Company and COPD foundation
7 September 2023 - Lupin Limited, an India-based global pharma company, announced on Wednesday that it has collaborated with US-based Mark Cuban Cost Plus Drug Company (Cost Plus Drugs), a company tha...
Certara Simcyp receives FDA grants for advanced pharmacokinetic modelling
29 August 2023 - Biosimulation specialist Certara (Nasdaq:CERT) announced on Tuesday that the Simcyp group has been awarded two grants from the US Food and Drug Administration (FDA) to expand its pred...
Sandoz's Tyruko (natalizumab-sztn) gains FDA approval as first biosimilar for relapsing MS
25 August 2023 - Generic and biosimilar medicines provider Sandoz, part of Swiss pharmaceutical company Novartis Pharma AG (SIX:NOVN) (NYSE:NVS), said on Friday that the US Food and Drug Administratio...